Evidence-Based Compounds for IBS
Irritable bowel syndrome involves gut-brain axis dysregulation, altered gut microbiome composition, increased intestinal permeability, and visceral hypersensitivity. Compounds with clinical evidence for reducing IBS symptoms through microbiome modulation, barrier repair, anti-spasmodic action, and anti-inflammatory mechanisms are ranked below.
This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.
Browse all compounds · Biological pathways · Molecular targets · All conditions
© Organiq Sweden AB · Patent pending EVE-PAT-2026-001